Why Brexit has doomed your pension

Brexit has sent shockwaves through the financial world and could have doomed some workers’ pensions.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Brexit will have a substantial impact on the lives of people across the UK, and one area where its effects are already being felt is in the pensions industry. Since 24 June, financial markets have been in risk-off mode. Investors have dumped equities and risky assets in favour of assets that are perceived to have less risk such as government bonds and gold.

This sudden rush towards government securities has pushed down yields, (as bond prices rise, yields fall) which is great news for borrowers but bad news for bond investors who are now getting a lower return on their investment.

More for less

The single largest buyers of government bonds (excluding central banks via QE) are pension funds. The high quality and long-term nature of government bonds makes them the perfect assets for pension funds that have to match today’s inflows from contributors to future liabilities or pension outflows.

With yields falling this task of matching inflows with future outflows is becoming harder and harder. Most pension funds target a return of 5% to 10% a year on their assets. With most government bonds now yielding less than 2%, it’s easy to see the scale of the problem facing the industry.

Defined benefit funds are the most at risk. According to research from Bank of America at the end of April, the average funded ratio of the top 100 US corporate defined benefit pension plans sat at 77%, and this figure was calculated before the post-Brexit yield slump. The funding ratio of 77% indicates that the $3trn pension universe surveyed is running a $500bn funding gap.

Unsustainable deficit 

Here in the UK, it’s estimated that 11m people are reliant on defined benefit pension schemes and after recent market movements it’s estimated that UK pension deficits hit a record £935bn this week.

There’s no doubt that this is a colossal sum and meeting these liabilities is going to cause a serious headache for the worst-offending companies.

For example, BT’s pension deficit has increased by more than 50% in 18 months (to the end of May). Analysts at investment bank Macquarie believe the deficit now stands at £10.6bn. To put this figure into some perspective in the year to 31 March 2016, BT reported a pre-tax profit of £2.6bn. Macquarie believes that considering the present deficit, BT will have to pay £1bn per annum through to 2030 to fill the pension black hole.

The big question now being asked is, will companies ever be out to meet these pension liabilities?

Unfortunately, there’s now a very real chance that many businesses won’t be able to meet these obligations as deficits at some companies eclipse profits. Meanwhile, the UK’s Pension Protection Fund, a government-sponsored lifeboat for collapsed pension schemes, only has a funding surplus of £4.8bn, that’s just 0.51% of the total value of pension deficits as reported last week.

The figures really speak for themselves. The UK’s pension deficit is only getting worse, and there seems to be no way out.

Protect yourself 

The best way to protect yourself from the upcoming pensions bombshell could be to look after your own pension by investing in shares. And the best way to invest for the highest return is to look to high-quality blue chips with international operations, sustainable dividends and records of achieving the best returns for investors. Companies such as Unilever, AstraZeneca and GlaxoSmithKline all meet these criteria, but there are many more. 

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Stack of one pound coins falling over
Investing Articles

Want to turn your ISA into a passive income machine? These 3 steps help

Christopher Ruane looks at a trio of factors he reckons could help an investor as they aim to earn passive…

Read more »

Investing For Beginners

2 FTSE shares that have been oversold in this stock market correction

Jon Smith reviews the recent market slump and points out a couple of FTSE shares he believes have been oversold…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As the stock market moves down, I’m taking the Warren Buffett approach!

Rather than getting nervous as markets move around, our writer is looking to the career of Warren Buffett to see…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Here’s how a stock market crash could be brilliant news for your retirement!

This writer isn't peering into a crystal ball trying to time the next stock market crash. Instead, he's making an…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

Down 93%, should I load up on this penny stock while it’s under 1p?

The small-cap company behind this penny stock is eyeing up a substantial global market opportunity. So why did it crash…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is Fundsmith Equity still worth holding in a Stocks and Shares ISA or SIPP in 2026?

The performance of the Fundsmith Equity fund has been shocking over the last two years. Is it still smart to…

Read more »

Young female hand showing five fingers.
Investing Articles

5 smart moves to make before the 2025/2026 ISA deadline

Taking advantage of the annual allowance isn’t the only smart move to make before the upcoming ISA deadline, says Edward…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Here’s the dividend forecast for Lloyds shares through to 2028

Can dividend forecasts tell investors much about the outlook for banking shares? Stephen Wright sets out what investors really need…

Read more »